Want to create an interactive transcript for this episode?
Podcast: Dr. Chapa’s OBGYN Clinical Pearls
Episode: Breast CA Medical Risk Reduction: USPSTF Sept 2019 Guidelines
Description: In Sept 2019, the USPTF revised and updated its 2013 recommendations on medications for risk reduction of primary breast cancer. Who qualifies for medical strategies? Which meds are recommended? In this session we will highlight the new USPSTF Guidelines, review the use of Prediction Models, and compare Tamoxifen, Raloxifene, and Aromatase Inhibitors.